Balyasny Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$928K Buy
14,497
+7,695
+113% +$506K ﹤0.01% 2256
2026
Q1
$484K Sell
6,802
-12,342
-64% -$973K ﹤0.01% 2383
2025
Q4
$1.57M Buy
19,144
+9,019
+89% +$703K ﹤0.01% 1987
2025
Q3
$760K Sell
10,125
-778,163
-99% -$58M ﹤0.01% 2230
2025
Q2
$58.4M Buy
+788,288
New +$54.9M 0.09% 283
2023
Q3
– Sell
-100,848
Closed -$8.19M – 2423
2023
Q2
$8.19M Buy
100,848
+95,473
+1,776% +$7.62M 0.02% 865
2023
Q1
$441K Buy
+5,375
New +$384K ﹤0.01% 1986

Other funds holding GEHC

Balyasny Asset Management's GEHC Position: Q2 2026 in Review

Balyasny Asset Management increased its GE HealthCare (GEHC) stake by 113% in Q2 2026, buying an estimated $506K and bringing the position to 14,497 shares worth $928K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Balyasny Asset Management first reported a position in GEHC in Q1 2023 and has held it in 7 quarters since. The position peaked at $58.4M in Q2 2025. 1,232 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Balyasny Asset Management held 14,497 shares of GE HealthCare worth $928K as of Q2 2026.
  • Balyasny Asset Management bought 7,695 GE HealthCare shares in Q2 2026, an estimated $506K.
  • GE HealthCare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2256 holding.
  • Balyasny Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 7 quarters since.
  • Balyasny Asset Management's GE HealthCare position peaked at $58.4M in Q2 2025.
  • 1,232 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.